News
FluMist, AstraZeneca and Influenza vaccine
Digest more
Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...
Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for ...
The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of those who develop the disease due to an oncogenic driver mutation. Tagrisso ...
AstraZeneca PLC closed 12.32% short of its 52-week high of £133.88, which the company achieved on September 3rd.
He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating tactic to get a better deal from the British government, including on what ...
Stocktwits on MSN8h
Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca
FibroGen, Inc. (FGEN) on Monday said that a Chinese regulator has approved the sale of its unit FibroGen International (Hong ...
AstraZeneca is now the second biggest company in Britain by market capitalization, with a flashy new $1.8 billion oval disc headquarters in Cambridge set to fully open by December.
While the numbers may seem high, they are still far below the pay of top executives in the United States, the study has found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback